Randomized controlled trial of behavioral treatment for comorbid obesity and depression in women: The Be Active Trial

International Journal of Obesity

Volumn 37, Issue 11, 2013, Pages 1427-1434

  Pagoto, S ^a   Schneider, K L ^b   Whited, M C ^c   Oleski, J L ^a   Merriam, P ^a   Appelhans, B ^d   Ma, Y ^a   Olendzki, B ^a   Waring, M E ^a   Busch, A M ^e   Lemon, S ^a   Ockene, I ^a   Crawford, S ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

^d RUSH UNIVERSITY   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

behavior therapy; depression; lifestyle intervention

Indexed keywords

LIPID;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BEHAVIOR THERAPY; BLOOD PRESSURE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT OUTCOME; WEIGHT CHANGE; WEIGHT REDUCTION;

ADULT; BEHAVIOR THERAPY; COMORBIDITY; DEPRESSION; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; OBESITY; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME; UNITED STATES; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 84887836076     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2013.25     Document Type: Article

References (45)

1. Pagoto SL, Schneider KL, Appelhans B, Curtin C, Hajduk A. Psychological co-morbidities of obesity. In: Pagoto SL (ed.). Psychological Co-Morbidities of Physical Illness: A Behavioral Medicine Perspective. 1st ed (Springer: New York, NY, USA, 2011).
2. Pagoto SL, Bodenlos JS, Kantor L, Gitkind M, Curtin C, Ma Y. Association of major depression and binge eating disorder with weight loss in a clinical setting. Obesity 2007; 15: 2557-2559.
3. Clark MM, Niaura R, King TK, Pera V. Depression, smoking, activity level, and health status: pretreatment predictors of attrition in obesity treatment. Addict Behav 1996; 21: 509-513.
4. Pekarik G, Blodgett C, Evans RG, Wierzbicki M. Variables related to continuance in a behavioral weight loss program. Addict Behav 1984; 9: 413-416.
5. Linde JA, Simon GE, Ludman EJ, Ichikawa LE, Operskalski BH, Arterburn D et al. A randomized controlled trial of behavioral weight loss treatment versus combined weight loss/depression treatment among women with comorbid obesity and depression. Ann Behav Med 2011; 41: 119-130.
6. Pagoto SL, Kantor L, Bodenlos JS, Gitkind M, Ma Y. Translating the Diabetes Prevention Program into a hospital-based weight loss program. Health Psychol 2008; 27: S91-S98.
7. U.S. Preventive Services Task Force. Screening and Interventions for Overweight and Obesity in Adults. Agency for Healthcare Research and Quality: Rockville, MD, USA, 2003, (Report No.: 00-4084).
8. Faulconbridge L, Wadden T, Berkowitz RI, Pulcini M, Treadwell T. Treatment of comorbid obesity and major depressive disorder: a prospective pilot study for their combined treatment. J Obes 2011; 2011: 870385.
9. Pagoto SL, Bodenlos JS, Schneider KL, Olendzki B, Spates RC, Ma Y. Initial investigation of behavioral activation therapy for co-morbid major depressive disorder and obesity. Psychotherapy 2008; 45: 410-415.
10. Hopko DR, Lejuez CW, Ruggiero KJ, Eifert GH. Contemporary behavioral activation treatments for depression: procedures, principles, and progress. Clin Psychol Rev 2003; 23: 699-717.
11. Lejuez CW, Hopko DR, Hopko SD. A brief behavioral activation treatment for depression. Treatment manual. Behav Modif 2001; 25: 255-286.
12. Cullen JM, Spates RC, Pagoto SL, Doran N. Behavioral activation treatment for major depressive disorder: A pilot investigation. Behav Anal Today 2006; 7: 151-166.
13. Porter JF, Spates RC, Smitham S. Behavioral activation group therapy in public mental health settings: a pilot investigation. Prof Psychol Res Pract 2004; 35: 297-301.
14. Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol 2006; 74: 658-670.
15. Jacobson NS, Dobson KS, Truax PA, Addis ME, Koerner K, Gollan JK et al. A component analysis of cognitive-behavioral treatment for depression. J Consult Clin Psychol 1996; 64: 295-304.
16. Schneider KL, Bodenlos JS, Ma Y, Olendzki B, Oleski J, Merriam P et al. Design and methods for a randomized clinical trial treating co-morbid obesity and major depressive disorder. BMC Psychiatry 2008; 8: 77.
17. Spitzer RL, Williams JB, Gibbon M, First MB. The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry 1992; 49: 624-629.
18. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol 1988; 56: 893-897.
19. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
20. Ryan P. sxd1.1: Update to random allocation of treatment to blocks. Stata Technical Bulletin 1999; 9: 36-37.
21. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. The Psychological Corporation: San Antonio, TX, USA, 1996.
22. Williams J. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1988; 45: 742-747.
23. Nelson M, Black AE, Morris JA, Cole TJ. Between-and within-subject variation in nutrient intake from infancy to old age: estimating the number of days required to rank dietary intakes with desired precision. Am J Clin Nutr 1989; 50: 155-167.
24. Liu K, Stamler J, Dyer A, McKeever J, McKeever P. Statistical methods to assess and minimize the role of intra-individual variability in obscuring the relationship between dietary lipids and serum cholesterol. J Chronic Dis 1978; 31: 399-418.
25. El Lozy M. Dietary variability and its impact on nutritional epidemiology. J Chronic Dis 1983; 36: 237-249.
26. Buzzard IM, Price KS, Warren RA. Considerations for selecting nutrient-calculation software: evaluation of the nutrient database. Am J Clin Nutr 1991; 54: 7-9.
27. Matthews CE, Freedson P, Hebert J, Stanek E, Ockene I, Merriam P. Comparison of physical activity assessment methods in the Seasonal Variation of Blood Cholesterol Levels Study. Med Sci Sports Exerc 2000; 32: 976-984.
28. Matthews CE, Hebert JR, Freedson PS, Stanek 3rd EJ, Merriam PA, Ebbeling CB et al. Sources of variance in daily physical activity levels in the seasonal variation of blood cholesterol study. Am J Epidemiol 2001; 153: 987-995.
29. Matthews CE, Freedson PS, Stanek EJ, Hebert JR, Merriam PA, Rosal MC et al. Seasonal variation of household, occupational, and leisure-time physical activity: Longitudinal analyses from the Seasonal Variation of Cholesterol Study. Am J Epidemiol, 2001; 153(2): 172-183.
30. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultra-centrifuge. Clin Chem 1972; 18: 499-502.
31. Myers GL, Kimberly MM, Waymack PP, Smith SJ, Cooper GR, Sampson EJ. A reference method laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements. Clin Chem 2000; 46: 1762-1772.
32. Myers GL, Cooper GR, Winn CL, Smith SJ. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements. Clin Lab Med 1989; 9: 105-135.
33. Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE. The importance of placebo effects in pain treatment and research. JAMA 1994; 271: 1609-1614.
34. DPP Research Group. The Diabetes Prevention Program (DPP): Description of lifestyle intervention. Diabetes Care 2002; 25: 2165-2171.
35. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007; 39: 1423-1434.
36. NICE. The treatment and management of depression in adults (Updated edition): The British Psychological Society and The Royal College of Psychiatrists 2010.
37. Martell CR, Addis ME, Jacobson NS. (eds). Depression in context. Strategies for guided action. W. W. Norton: New York, NY, USA, 2001.
38. Lejuez CW, Hopko DR, Acierno R, Daughters SB, Pagoto SL. Ten year revision of the Brief Behavioral Activation Treatment for Depression (BATD): revised treatment manual (BATD-R). Behav Modif 2011; 35: 111-161.
39. Littell R, Milliken G, Stroup W, Wolfinger R. SAS System for Mixed Models. SAS Institute Inc: Cary, NC, USA, 1996.
40. Chuang-Stein C, Tong DM. The impact and implication of regression to the mean on design and analysis of medical investigations. Stat Methods Med Res 1997; 6: 115-128.
41. Molenberghs G, Verbeke G. Models for Discrete Longitudinal data. Springer Science: New York, NY, USA, 2005.
42. DPP Research Group. Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res 2004; 12: 1426-1434.
43. Shafer AB. Meta-analysis of factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol 2006; 62: 124-146.
44. Moran PJ, Mohr DC. The validity of the Beck Depression Inventory and Hamilton Rating Scale for depression items in the assessment of depression among patients with multiple sclerosis. J Behav Med 2005; 28: 35-41.
45. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): A short screening scale for use in the general population. Psychol Med 2005; 35: 245-256.